用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Phosphatidylserine'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页284 条记录, 当前第1/29页。
公开号 公开日 申请号 申请日
1. CN103635181A 2014/3/12
专利标题:The microencapsulation method of phosphatidylserine 法律状态
专利权人


2. US2014065148A1 2014/3/6 US201313936802 2013/7/8
专利标题:TREATMENT METHODS USING ANTIBODIES TO AMINOPHOSPHOLIPIDS 法律状态
专利权人UNIV TEXAS [US];
Disclosed are the surprising discoveries that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are stable and specific markers accessible on the luminal surface of tumor blood vessels, and that the administration of an anti-aminophospholipid antibody alone is sufficient to induce thrombosis, tumor necrosis and tumor regression in vivo. This invention therefore provides anti-aminophospholipid antibody-based methods and compositions for use in the specific destruction o...


3. US8658768B2 2014/2/25
专利标题:Method for enhancing phagocytosis of phosphatidylserine-exposing cells 法律状态
专利权人Mosamedix B.v.;
An Annexin A5 variant comprising one or more RGD (Arg-Gly-Asp) sequences is suitable for use in the treatment of a disease in mammals including humans wherein augmentation of phagocytosis is a desired effect of treatment. The Annexin A5 variant can e.g. be used in the treatment of chronic inflammatory diseases such as atherosclerotic plaque or in the treatment of COPD. At least one RGD sequence may substitute sequences of three amino acids within the range 1-19 or other regions of the amino acid...


4. WO2014018535A1 2014/1/30 WO2013US51688 2013/7/23
专利标题:REGULATING THE INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYLSERINE 法律状态
The present disclosure provides methods for modulating the interaction between a TAM ligand and a lipid membrane containing phosphatidyl serine (PtdSer). In one example, such methods use a TAM receptor agonist having a PtdSer -containing lipid bilayer membrane with Gas6 and/or Protein S bound to the membrane to activate signaling from one or more TAM receptors and treat an autoimmune disease. In another example, methods are provided for treating a subject with a pathological condition characteri...


5. CN102716098B 2014/1/15 CN20121222235 2012/6/29
专利标题:A kind of cefditoren pivoxil cephalosporins lipidosome solid preparation 法律状态


6. CN103509047A 2014/1/15
专利标题:The extraction process of phosphatidylcholine and the preparation method of phosphatidylserine in a kind of krill source 法律状态
专利权人


7. CN102716082B 2014/1/15
专利标题:A kind of cefoxitin sodium lipidosome injection 法律状态


8. US2013337088A1 2013/12/19 US201313970983 2013/8/20
专利标题:METHODS FOR TREATING SCARS AND AGING SKIN 法律状态
Beneficial topical compositions for treating scar or aging skin are provided. In one embodiment, the compositions include Bulbine frutescens, Centella asiatica and a phenol derived from olives, such as oleuropein. The composition may be used in the treatment of scars formed during surgery. The composition may also be used cosmeceutically in the treatment of aged skin, and may include phosphatidylserine, vitamins, and other beneficial anti-aging ingredients.


9. KR20130137578A 2013/12/17 KR20130145867 2013/11/28
专利标题:COMPOSITION FOR IMPROVEMENT OF SKIN WRINKLE CAUSED BY ULTRA VIOLET RADIATION COMPRISING PHOSPHATIDYLSERINE 法律状态
专利权人DOOSAN CORP [KR];


10. WO2013184678A1 2013/12/12 WO2013US44108 2013/6/4
专利标题:MOLECULAR PROBES FOR MULTIMODALITY IMAGING OF ANIONIC MEMBRANE SURFACES 法律状态
Embodiments provide dual modality probes for imaging phosphatidylserine (PS) exposure and other anionic membrane surfaces. In various embodiments, the probes were constructed by utilizing a) the high selectivity of synthetic zinc (II) dipicolylamine coordination complexes (Zn-DPA) for targeting externalized PS which over-expresses in apoptotic and necrotic cells, b) a near-infrared (NIR) dye for optical imaging, and c) a widely used clinically approved radionuclide for PET (or SPECT) imaging. A ...



首页123456下页尾页284 条记录, 当前第1/29页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文